Summary
We report the case of a young woman, with mixed connective tissue disease (MCTD), associated with disabling pulmonary hypertension and presence of the “lupus anticoagulant”. The “lupus anticoagulant”, an antibody directed against phospholipid components, was linked in our patient to extensive thrombophlebitis and premature labor. Raynaud's phenomenon progressed towards finger necrosis in spite of optimal vasodilating treatment. The part played by the “lupus anticoagulant” in pulmonary hypertension remains to be established. Both these complications responded to prednisolone therapy, but the improvement was limited and short-lived.
Similar content being viewed by others
References
Sharp, G.C., Irvin, W.S., Tan, E.M., Gould, R.G., Holman, H.R. Mixed connective-tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972, 52, 148–159.
Alarcon-Segovia, D., Palacios, R. Human postthymic precursor cells in health and disease. IV. Abnormalities in immunoregulatory T cell circuits in mixed connective tissue disease. Arthritis Rheum 1981, 24, 1486–1494.
Agia, G.A., Reddy, V.C., Maltby, J., Madigan, N.P., Sandock, K., Hurst, D.J. Pulmonary involvement in mixed connective tissue disease. Am Rev Resp Dis 1980, (suppl.) 121, 105–117.
Esther, J.H., Sharp, G.C., Agia, G., Hurst, D.J. Pulmonary hypertension in patients with mixed connective tissue disease and antibody to nuclear ribonucleo-protein. Arthritis Rheum, 1981, 24, S 105.
Grant, K.D., Adams, L.E., Hess, E.V. Mixed connective tissue disease, a subset with sequential clinical and laboratory features. J Rheumatol 1981, 8, 587–598.
Rosenberg, A.M., Petty, R.E., Cumming, G.R., Koehler, B.E. Pulmonary hypertension in a child with mixed connective tissue disease. J Rheumatol 1979, 6, 700–704.
Wiener-Kronish, J.P., Solinger, A.M., Warnock, M.L., Chrug, A., Ordonez, N., Golden, J.A. Severe pulmonary involvement in mixed connective tissue disease. Am Rev Resp Dis 1981, 124, 499–503.
Sullivan, W.D., Hurst, D.J., Harmon, C.E., Esther, J.H., Agia, G.A., Maltby, J.D., Lillard, S.B., Held, C.N., Wolfe, J.F., Sunderrajan, E.V., Maricq, H.R., Sharp, G.C. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine 1984, 63, 92–107.
Graziano, F.M., Friedman, L.C., Grossman, J. Pulmonary hypertension in a patient with mixed connective tissue disease: clinical and pathologic findings, and review of literature. Clin Exper Rheumatol 1983, 1, 251–255.
Manthorpe, R., Elling, H., Vandermeulen, J.T., Freiesleben Sörensen, S. Two fatal cases of mixed connective tissue disease. Scand J Rheumatol 1980, 9, 7–10.
Singsen, B.H., Swanson, V.L., Bernstein, B.H., Heuser, E.T., Hanson, V., Landing, B.H. A histologic evaluation of mixed connective tissue disease in childhood. Am J Med 1980, 68, 710–717.
Salerni, R., Rodnan, G.P., Leon, D.F., Shaver, J.A. Pulmonary hypertension in CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med 1977, 86, 394–399.
Cryer, P.E., Kissans, J.M. Clinico-pathologic conference. Mixed connective tissue disease. Am J Med 1978, 65, 833–842.
Jones, M.B., Osterholm, R.K., Wilson, R.B., Martin, F.H., Commers, J.R., Backmayer, J.D. Fatal pulmonary hypertension and resolving immune complex glomerulonephritis in mixed connective tissue disease: Case report and review of literature. Am J Med 1978, 65, 855–863.
Elias, M., Eldor, A. Thromboembolism in patients with the “lupus” type circulating anticoagulant. Arch Intern Med 1984, 144, 510–515.
Stranden, E., Roald, O.K., Krohg, K. Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist ketanserin. Br Med J 1982, 285 1069–1071.
Rodeheffer, R.J., Rommer, J.A., Wigley, F., Smith, C.R. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon. N Engl J Med 1983, 308, 880–883.
Sharp, G.C. Mixed connective tissue disease — over-lap syndrome. Clin Rheum Dis 1975, 1, 561.
Prystowsky, S.D. Mixed connective tissue disease. West J Med 1980, 132, 288–293.
Boxer, M., Ellman, L., Carvalho, A. The lupus anticoagulant. Arthritis Rheum 1976, 19, 1244–1248.
Albert, J., Ekoe, J.M., Cunningham, M., Humair, L. Circulating anticoagulant in CREST syndrome. Br J Rheumatol 1984, 23, 20–23.
Waddell, C.C., Brown, J.A. The lupus anticoagulant in 14 male patients. JAMA 1982, 248, 2493–2495.
Soulier, J.P., Boffa, M.C. Avortements à répétition, thromboses et anticoagulant circulant antithromboplastine. Nouv Presse Med 1980, 9, 859–864.
Lechner, K. Acquired inhibitors in non-hemophilic patients. Haemostasis 1974, 3, 65–93.
Mueh, J.R., Herbst, K.D., Rapaport, S.I. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 1980, 92, 156–159.
Thiagarajan, P., Shapiro, S.S., Demarco, L. Monoclonal immunoglobulin M-lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. J Clin Invest 1980, 66, 397–405.
Byron, M.A. The clotting defect in SLE. Clin Rheum Dis 1982, 8, 137–151.
Exner, T., Rickard, K.A., Kronenberg, H. Studies on phospholipids in the action of a lupus coagulation inhibitor. Pathology 1975, 7, 319–328.
Gladman, D.D., Urowitz, M.B. Venous syndromes and pulmonary embolism in systemic lupus erythematosus. Ann Rheum Dis 1980, 39, 340–343.
Boey, M.L., Colaco, C.B., Gharav, A.E., Elkon, K.B., Loizou, S., Hughes, G.R.V. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J 1983, 287, 1021–1023.
Angles-Cano, E., Sultan, Y., Clauvel, J.P. Predisposing factors to thrombosis in systemic lupus erythematosus. Possible relation to endothelial cell damage. J Lab Clin Med 1979, 94, 312–323.
Schleider, M.A., Nachman, R.L., Jaffe, E.A., Co
Carreras, L.O., Machin, S.J., Deman, R., Defreyn, G., Vermylen, J., Spitz, B., Vanassche, A. Arterial thrombosis, intrauterine death and lupus anticoagulant: detection of an immunoglobulin interfering with prostacyclin formation. Lancet 1981, 1, 244–246.
Carreras, L.O., Vermylen, J., Spitz, B., Van Assche, A. Lupus anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br J Obstet Gynaecol 1981, 88, 890–894.
Gardlund, B., The lupus inhibitor in thromboembolic disease and intrauterine death in the absence of systemic lupus. Acta Med Scand 1984, 215, 293–298.
Firkin, B.G., Howard, M.A., Radford, N. Possible relationship between lupus inhibitor and recurrent abortion in young women. Lancet 1980, 2, 366.
Hughes, G.R.V. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. Br Med J 1983, 287, 1088–1089.
Harris, E.N., Englert, H., Derue, G., Hughes, G.R.V., Gharavi, A. Antiphospholipid antibodies in acute Guillain-Barré syndrome. Lancet 1983, 2, 1361–1362.
Seibold, J.R., Trontell, M.C. Anticentromere antibody and primary pulmonary hypertension. J Rheumatol 1982, 9, 607–609.
Asherson, R.A., Mackworth-Young, C.G., Boey, M.L., Hull, R.G., Saunders, A., Gharavi, A.E., Hughes, G.R.V. Pulmonary hypertension in systemic lupus erythematosus. Br Med J 1983, 287, 1024–1025.
Walcott, G., Burchell, H.B., Brown, A.L. Primary pulmonary hypertension. Am J Med 1970, 49, 70–79.
Fahey, P.J., Utell, M.J., Condemi, J.J., Green, R., Hyde, R.W. Raynaud's phenomenon of the lung. Am J Med 1984, 76, 263–269.
Blunt, R.J., Porter, J.M. Raynaud syndrome. Semin Arthritis Rheum, 1981, 10, 282–308.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hainaut, P., Lavenne, E., Magy, J.M. et al. Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease. Clin Rheumatol 5, 96–101 (1986). https://doi.org/10.1007/BF02030976
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02030976